251120 — Bio-FD&C Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Bio-FD&C Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	3,293	5,443	5,585	4,501	6,666
Depreciation
Amortisation
Non-Cash Items	334	444	66.7	559	-254
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-566	-1,364	-692	-235	-455
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	3,687	5,573	6,047	6,037	7,279
Capital Expenditures	-7,017	-225	-2,329	-1,297	-1,049
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	4,660	-30,380	-976	-9,008	-1,934
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-2,357	-30,605	-3,306	-10,305	-2,982
Financing Cash Flow Items	0	—	—	—	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	582	31,478	-2,225	-54.2	-1,195
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	2,009	6,431	472	-4,223	3,099